| 000 | 01446 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515104814.0 | ||
| 264 | 0 | _c20080715 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1099-1077 | ||
| 024 | 7 |
_a10.1002/hup.921 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChawla, Bharat | |
| 245 | 0 | 0 |
_aLong-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial. _h[electronic resource] |
| 260 |
_bHuman psychopharmacology _cApr 2008 |
||
| 300 |
_a211-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzodiazepines _xadministration & dosage |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aOverweight _xcomplications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPsychotic Disorders _xcomplications |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aLuxton-Andrew, Heather | |
| 773 | 0 |
_tHuman psychopharmacology _gvol. 23 _gno. 3 _gp. 211-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hup.921 _zAvailable from publisher's website |
| 999 |
_c17726891 _d17726891 |
||